An investigator reported 10-year follow-up data from a phase 3 trial of extended vs limited pelvic lymph node dissection during radical prostatectomy.

Long-term follow-up consistent with earlier report, a hint of benefit in high-grade diseas ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.

In a phase 3 trial, participants with higher-grade prostate cancer saw oncologic benefits from extended lymph node dissection during radical prostatectomy. Extended pelvic lymph node dissection (ePLND ...